CASIOPEA ESM2M acquires 51% stake in FARSENS - MarketLine Financial Deals

CASIOPEA ESM2M acquires 51% stake in FARSENS

CASIOPEA ESM2M acquires 51% stake in FARSENS - MarketLine Financial Deals
CASIOPEA ESM2M acquires 51% stake in FARSENS
Published May 09, 2013
3 pages — Published May 09, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

CASIOPEA ESM2M s.l, a developer and marketer of a platform for hosting and controlling applications, along with Ambar Venture Capital, ARTECHE LANTEGI ELKARTEA, S.A and Ars Machina, has acquired a 51% stake in FARSENS, S.L., a developer of digital wireless sensors.

  
Source:
Document ID
MA139515_130611
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "CASIOPEA ESM2M acquires 51% stake in FARSENS" May 09, 2013. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CASIOPEA-ESM2M-acquires-51-stake-in-FARSENS-2052-95063>
  
APA:
MarketLine Financial Deals. (2013). CASIOPEA ESM2M acquires 51% stake in FARSENS May 09, 2013. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CASIOPEA-ESM2M-acquires-51-stake-in-FARSENS-2052-95063>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.